Table 2 Demographic, breed and surgery variables; data are mean (± SD) or number of dogs (%)
Variable | Robenacoxib | Placebo | Total | P value* |
|---|---|---|---|---|
Number of dogs | 119 (49.8%) | 120 (50.2%) | 239 (100.0%) | Â |
Age (years) | 6.2 (±4.3) | 5.5 (±3.8) | 5.8 (±4.0) | 0.23 |
Body weight (kg), pre-enrollment | 20.0 (±12.2) | 22.9 (±15.1) | 21.5 (±13.8) | 0.10 |
Sex and neutered status | Â | Â | Â | 0.068 |
 Female intact | 40 (33.6%) | 33 (27.5%) | 73 (30.5%) | |
 Female spayed | 36 (30.3%) | 34 (28.3%) | 70 (29.3%) | |
 Male intact | 7 (5.9%) | 20 (16.7%) | 27 (11.3%) | |
 Male castrated | 36 (30.3%) | 33 (27.5%) | 69 (28.9%) | |
Breed | Â | Â | Â | 0.65 |
 Labrador Retriever | 11 (9.2%) | 14 (11.7%) | 25 (10.5%) | |
 Golden Retriever | 10 (8.4%) | 5 (4.2%) | 15 (6.3%) | |
 Mix-Labrador Retriever | 5 (4.2%) | 7 (5.8%) | 12 (5.0%) | |
 Shih Tzu | 6 (5.0%) | 5 (4.2%) | 11 (4.6%) | |
 Various other breeds | 87 (73.1%) | 89 (74.2%) | 176 (73.6%) | |
Type of surgery | Â | Â | Â | 0.62 |
 Skin tumor removal (≥ 8 cm in size) | 31 (26.1%) | 39 (32.5%) | 70 (29.3%) | |
 Ovariohysterectomy | 29 (24.4%) | 26 (21.7%) | 55 (23.0%) | |
 Cystotomy | 18 (15.1%) | 17 (14.2%) | 35 (14.6%) | |
 Gastropexy | 12 (10.1%) | 16 (13.3%) | 28 (11.7%) | |
 Other soft tissue surgery | 29 (24.4%) | 22 (18.3%) | 51 (21.3%) |